FDA Archives - Onco'Zine

Home Tags FDA

Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t...

Arthur Allen - June 22, 2023

FDA Priority Review of NDA for Nirogacestat for the Treatment of...

Editorial Team - February 27, 2023

Project Optimus: How to Prepare for Success

Julie Bullock, Pharm.D. - October 21, 2022

Low magnification micrograph of mantle cell lymphoma of the terminal ileum. Endoscopic biopsy. H&E stain. Photo Courtesy: 2020. Nephron. This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license.

U.S. FDA approves Phase 3 Study Design for Zilovertamab in the...

Editorial Team - January 4, 2022

More Education is Needed to Increase Provider Geriatric Assessments for Older...

Editorial Team - October 16, 2020

Disitamab Vedotin Receives FDA Breakthrough Therapy Designation for Treatment of Urothelial...

Peter Hofland - September 25, 2020

Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Peter Hofland - June 24, 2020

Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith - December 20, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

FDA Approves New Drug for Advanced Bladder Cancer

Peter Hofland - December 19, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

Peter Hofland - September 16, 2019

12 3 Page 1 of 3

LATEST NEWS

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Peter Hofland - November 25, 2023

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Editorial Team - November 24, 2023

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Brandon H. McNaughton, Ph.D. - November 23, 2023

Activating Bitter Taste Receptors May Kill Certain Cancer Cells

Editorial Team - November 22, 2023

GRP78 – A Promising Target for CAR T-cells Helps Cancer Trick the Immune System

Editorial Team - November 21, 2023

Press Releases | Cancer

Northeast Delta HSA partners with True Releaf CBD/Hemp Store to provide Drug Deactivation and Disposal Container November 28, 2023
Northeast Delta Human Services Authority (NEDHSA) unveiled a Deterra® Drug Deactivation and Disposal System Container on Tuesday, November 28, at True Releaf CBD/Hemp Store, located at 611 N. 4th Street, Monroe, La. 71201. This is the first partnership between a state agency and a...
Call Declined: New podcast follows the story of two artists, whose lives were transformed in prison after the systems meant to protect their wellbeing failed them November 28, 2023
Created by Lemonada Media and sponsored by the Sozosei Foundation, Call Declined follows the story of two talented artists, Kamisha Thomas and Aimee Wissman, whose lives were profoundly transformed in prison after the systems meant to protect and ensure their wellbeing failed them. Hosted...
Convergent Dental announces commercial availability of Solea® Protect™ to strengthen dental enamel using the Solea® All-Tissue Dental Laser November 28, 2023
Studies have shown that using Solea Protect in conjunction with fluoride is up to six times more effective at reducing mineral loss in tooth enamel than fluoride alone. WALTHAM, Mass., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Tooth decay, also known as dental caries, can affect patients of all...